Child and adolescent psychiatrists' attitudes and practices prescribing second generation antipsychotics

Journal of Child and Adolescent Psychopharmacology

Volumn 24, Issue 2, 2014, Pages 90-93

  Rodday, Angie Mae ^a,b   Parsons, Susan K ^a,b   Correll, Christoph U ^c   Robb, Adelaide S ^d   Zima, Bonnie T ^e   Saunders, Tully S ^a   Leslie, Laurel K ^a,b  

^a TUFTS MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Floating Hospital for Children Tufts Medical Center ^*  (United States)

^d CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

AGGRESSION; ARTICLE; AUTISM; BIPOLAR DISORDER; CAUCASIAN; CLINICAL PRACTICE; DISRUPTIVE BEHAVIOR; ETHNICITY; FEMALE; FOOD AND DRUG ADMINISTRATION; HUMAN; JUVENILE DELINQUENCY; MALE; MEDICAL SOCIETY; MOOD DISORDER; NORMAL HUMAN; PHYSICIAN ATTITUDE; PRESCRIPTION; PSYCHIATRIST; PSYCHOPHARMACOTHERAPY; SCHIZOPHRENIA; ADOLESCENT; ATTENTION DEFICIT AND DISRUPTIVE BEHAVIOR DISORDERS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; CHILD PSYCHIATRY; CONDUCT DISORDER; DRUG EFFECTS; HEALTH PERSONNEL ATTITUDE; INFORMATION PROCESSING; MOOD DISORDERS; OFF LABEL DRUG USE; PSYCHIATRY; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

ADOLESCENT; ADOLESCENT PSYCHIATRY; AGGRESSION; ANTIPSYCHOTIC AGENTS; ATTENTION DEFICIT AND DISRUPTIVE BEHAVIOR DISORDERS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; ATTITUDE OF HEALTH PERSONNEL; CHILD; CHILD PSYCHIATRY; CONDUCT DISORDER; DATA COLLECTION; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MOOD DISORDERS; OFF-LABEL USE; PRACTICE PATTERNS, PHYSICIANS'; PSYCHIATRY;

EID: 84897440977     PISSN: 10445463     EISSN: 15578992     Source Type: Journal    
DOI: 10.1089/cap.2013.0133     Document Type: Article

References (15)

1. Agency for Healthcare, Research, and Quality: Comparative effectiveness of first and second generation antipsychotics in the pedi-atric and young adult populations. Rockville MD:, Agency for Healthcare Research and Quality; 2010.
2. Association of American Medical Colleges: Center for Workforce Studies: 2008 Physician Specialty Data. Washington DC: Association of American Medical Colleges; 2008.
3. Birnbaum ML, Saito E, Gerhard T, Winterstein A, Olfson M, Kane JM, Correll CU: Pharmacoepidemiology of antipsychotic use in youth with ADHD: Trends and clinical implications. Curr Psychiatry Rep 15:382, 2013.
4. Correll CU, Sheridan EM, DelBello MP: Antipsychotic and mood stabilizer efficacy and tolerability in pediatric and adult patients with bipolar I mania: A comparative analysis of acute, randomized, placebo-controlled trials. Bipolar Disorders 12:116-141, 2010.
5. Crystal S, Olfson M, Huang C, Pincus H, Gerhard T: Broadened use of atypical antipsychotics: safety, effectiveness, and policy challenges. Health Aff (Millwood) 28:w770-w781, 2009.
6. Jensen PS, Youngstrom EA, Steiner H, Findling RL, Meyer RE, Malone RP, Carlson GA, Coccaro EF, Aman MG, Blair J, Dougherty D, Ferris C, Flynn L, Green E, Hoagwood K, Hutch-inson J, Laughren T, Leve LD, Novins DK, Vitiello B: Consensus report on impulsive aggression as a symptom across diagnostic categories in child psychiatry: Implications for medication studies. J Am Acad Child Adolesc Psychiatry 46:309-322, 2007.
7. Knapp P, Chait A, Pappadopulos E, Crystal S, Jensen PS, T-MAY Steering Group: Treatment of Maladaptive Aggression in Youth (T-MAY). CERT Guidelines I. Family engagement, assessment & diagnosis, and initial management. Pediatrics 129:1562-1576, 2012.
8. Maayan L, Correll CU: Weight gain and metabolic risks associated with antipsychotic medications in children and adolescents. J Child Adolesc Psychopharmacol 21:517-535, 2011.
9. Needle JS, Mularski RA, Nguyen T, Fromme EK: Influence of personal preferences for life-sustaining treatment on medical decision making among pediatric intensivists. Crit Care Med 40:2464-2469, 2012.
10. Olfson M, Blanco C, Liu SM, Wang S, Correll CU: National trends in the office-based treatment of children, adolescents, and adults with antipsychotics. Arch Gen Psychiatry 69:1247-1256, 2012.
11. Pappadopulos E, Macintyre Ii JC, Crismon M, Findling RL, Malone RP, Derivan A, Schooler N, Sikich L, Greenhill L, Schur SB, Felton CJ, Kranzler H, Rube DM, Sverd J, Finnerty M, Ketner S, Siennick SE, Jensen PS: Treatment recommendations for the use of anti-psychotics for aggressive youth (TRAAY). Part II. J Am Acad of Child Adolesc Psychiatry 42:145-161, 2003.
12. Pappadopulos E, Rosato NS, Correll CU, Findling RL, Lucas J, Crystal S, Jensen PS: Experts' recommendations for treating mal-adaptive aggression in youth. J Child Adolesc Psychopharmacol 21:505-515, 2011.
13. Schur SB, Sikich L, Findling RL, Malone RP, Crismon M, Derivan A, Macintyre Ii JC, Pappadopulos E, Greenhill L, Schooler N, Van Orden K, Jensen PS: Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part I: A review. J Am Acad of Child Adolesc Psychiatry 42:132-144, 2003.
14. Scotto Rosato N, Correll CU, Pappadopulos E, Chait A, Crystal S, Jensen PS, Treatment of Maladaptive Youth Steering Committee: Treatment of Maladaptive Aggression in Youth (T-MAY). CERT Guidelines II. Psychosocial interventions, medication treatments, and side effects management. Pediatrics; 2012.
15. Shekelle P, Maglione M, Bagley S, Suttorp M, Mojica WA, Carter J, Rolón C, Hilton L, Zhou A, Chen S, Glassman P, Newberry S: Efficacy and Comparative Effectiveness of Off-Label Use of Atypical Antipsychotics. Comparative Effectiveness Review No. 6. (Prepared by the Southern California/RAND Evidence-Based Practice Center). Rockville, MD: Agency for Healthcare Research & Quality; 2007.